CD44 and Parkinson disease: A recent study has suggested that neuroinflammation in response to neurodegenerative disease such as the toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson’s disease is repressed in CD44-deficient mice22.